KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

ClearPoint Neuro (CLPT) Short term Debt (2018 - 2020)

Historic Short term Debt for ClearPoint Neuro (CLPT) over the last 6 years, with Q3 2020 value amounting to $73985.0.

ClearPoint Neuro's Short term Debt changed N/A to $73985.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $73985.0, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2014, which is 4134.89% down from last year.
Per ClearPoint Neuro's latest filing, its Short term Debt stood at $73985.0 for Q3 2020.
ClearPoint Neuro's 5-year Short term Debt high stood at $296677.0 for Q2 2020, and its period low was $22295.0 during Q2 2018.